Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease
Carrasquilla GD, Ängquist L, Sørensen TIA, et al.
Diabetologia. Pub. online 12 Dec 2023.
Leggi
Breaking news
Continuous glucose monitoring systems in non-insulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Oliva Morgado Ferreira R, Trevisan T, Pasqualotto E, et al.
Diabetes Technology & Therapeutics. Pub. online 13 Dec 2023.
Leggi
Increased circulating FGF21 level predicts the burden of metabolic demands and risk of vascular diseases in adults with type 2 diabetes
Liu Z, Peng Y, Li S, et al.
BMC Endocr Disord. 2023;23(1):272.
Leggi
Occurrence of gastrointestinal adverse events upon glp-1 receptor agonist initiation with concomitant metformin use: a post hoc analysis of LEADER, STEP 2, SUSTAIN 6, and PIONEER 6
Klein KR, Clemmensen KKB, Fong E, et al.
Diabetes Care. 2023:dc231791.
Leggi
Effect of the dual sodium‐glucose co‐transporter‐1 and ‐2 inhibitor sotagliflozin on renal outcomes in type 1 diabetes and type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials
Bantounou MA, Sardellis P, Thuemmler R, et al.
Diabetes Obes Metab. Pub. online 29 Nov 2023.
Leggi
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
Ray KK, Nicholls SJ, Li N, et al.
The Lancet Diabetes & Endocrinology. Pub. online 4 Dec 2023.
Leggi
Patterns of telemedicine use and glycemic outcomes of endocrinology care for patients with type 2 diabetes
Zupa MF, Vimalananda VG, Rothenberger SD, et al.
JAMA Netw Open. 2023;6(12):e2346305.
Leggi
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
The EMPA-KIDNEY Collaborative Group
The Lancet Diabetes & Endocrinology. Pub. online 4 Dec 2023.
Leggi
Use of voice-based conversational artificial intelligence for basal insulin prescription management among patients with type 2 diabetes: a randomized clinical trial
Nayak A, Vakili S, Nayak K, et al.
JAMA Netw Open. 2023;6(12):e2340232.
Leggi
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia
Corpeleijn WE, de Waal WJ, Schipper HS, Wiegman A
Diabetologia. Pub. online 30 Nov 2023.
Leggi